Trial intelligence / Profile preview

Vitamin D administration for anemia treatment in hemodialysis ESRD patients with vitamin D deficiency

IRCT201505152417N17Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of vitamin d in end-stage kidney disease (ESKD) and anaemia, sponsored by Isfahan University of Medical Sciences. Started Oct 2014; status: completed.

02

Drugs

vitamin d
03

Conditions

end-stage kidney disease (ESKD)anaemia

Beyond the preview

Go deeper on IRCT201505152417N17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201505152417N17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call